(TSG) The German science magazine Quarks confirms in this article: “mRNA-“vaccines” offer many advantages. The physicians would not necessarily have to inject the “vaccine”. Most mRNA-“vaccines” are directly nasally administered. This seems to make sense, since many infections start in the upper mucous membranes“. Why has Quarks since removed the remark from the article? To what extent has the leadership of the armed forces analyzed the risks arising from such a scenario?
The journalist Candice Vacle (Reseau International, Investig’Action et Mediapart) drew the author’s attention to the work of Dr. Alexandra Henrion-Caude, a french geneticist. Dr. Henrion-Caude was director of the National Institute of Health and Medical Research (Inserm) in Paris. The Inserm research and development institution is under the authority of the Ministère de la Santé (Ministry of Health) and the Ministère de la Recherche (Ministry of Research) of the French Republic.
Dr. Henrion-Caude explains in the video from minute 33:16 to 37:35 that the swab used for a PCR test is inserted into the nasopharynx in order to extract cells from the ethmoid by rubbing. The ethmoid contains the thin, sensitive, fragile cribriform plate. This plate is perforated with fine holes. These holes are traversed by nerve cells (neurons) of the olfactory nerve. Thus the cribriform plate can be targeted to deliver nanoparticulated drugs and “vaccines” directly to the brain. The tip of the swab coated with nanoparticles hits exactly the right spot so that the nanoparticles can reach the inside of the brain.
If the virus SARS-CoV-2 is able to penetrate masks and spread over distances of up to 5 feet / 1.5 meters (see point 3), why does a swab have to be inserted through the nose about 2 inches / 5 cm deep into the nasopharynx to take the cell sample for the PCR test? Because the swabs inject nanoparticles into the brain of the test victims?
France’s Haute Autorité de Santé (Health Authority, HAS) recommends saliva samples as an alternative – but only for test subjects who show symptoms. The HAS also recommends oral swabs (oropharyngeal swabs) for RT-PCR testing in asymptomatic individuals where nasopharyngeal swabs are contraindicated.
If SARS-CoV-2 is as easily transmitted as WHO and its affiliated health authorities claim, what is the point of the misleading distinction between symptomatic and asymptomatic? This distinction has never been made in the history of medicine. It is an invention of the test manufacturers and the makers of the pandemic. It would be much less intrusive, easier and safer to collect saliva from the tongue and cells from the inside of the cheek. However, if you want to inject nanoparticles into the brain via the nasopharynx, you need a pretext. Independent laboratory tests of the swabs can quickly provide clarity here.